Psychedelics Legislation Gains Momentum
Terri D'Arrigo
Psychiatric News February 16, 2023 DOI: 10.1176/appi.pn.2023.03.3.4 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | News report Peer reviewed |
|---|---|
| Topics | Ayahuasca LSD Mescaline Psilocybin |
| Keywords | Decriminalization Legislation Hallucinogen Possession linguistics Law |
| Key points | From January 1, 2019, to September 28, 2022, 25 states considered 74 bills to reform laws restricting psychedelic access or to fund research on reform, and 10 bills were signed into law by seven states. The text states that psychedelics research has not yet yielded supporting evidence on safety and efficacy. |
Abstract
Bills that would decriminalize the use of psychedelics are popping up faster than magic mushrooms, but the field of psychedelics research has yet to yield supporting evidence about their safety and efficacy. Legislative reform regarding psychedelics is gaining ground, a study in JAMA Psychiatry has found. From January 1, 2019, to September 28, 2022, 25 states considered 74 bills that proposed to reform existing laws restricting access to psychedelic drugs or proposed further research into reform legislation, and 10 of those bills had been signed into law by seven states.